Clinical Trial Update: Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Spinal Cord Injury [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy trial of KAI-1678 for spinal cord injury pain has completed. The document notes the study status as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• KAI-1678

Snippet

Sponsor: KAI Pharmaceuticals | Conditions: Spinal Cord Injury | Phase 2 | Status: COMPLETED